Columbia University Medical Center

Health Buzz: Biomarker Predicts Benefits of Chemo on Colon Cancer

​”The problem is that we don’t have an easy way to single out these patients before they relapse and accurately predict who could benefit from postsurgical, or adjuvant, chemotherapy,” Dr. Piero Dalerba, assistant professor of medicine, pathology and cell biology at Columbia University Medical Center and the Herbert Irving Comprehensive Cancer Center, said in a press release.